Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis
Authors
Keywords
Diabetic nephropathy, SGLT2 inhibitors, Dapagliflozin, Rats, Reno protective effect
Journal
LIFE SCIENCES
Volume -, Issue -, Pages 119018
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.lfs.2021.119018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
- (2020) M. Arow et al. Cardiovascular Diabetology
- Fucoidan protects against subacute diazinon-induced oxidative damage in cardiac, hepatic, and renal tissues
- (2020) Mohamed M. Abdel-Daim et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Fucoidan Ameliorates Oxidative Stress, Inflammation, DNA Damage, and Hepatorenal Injuries in Diabetic Rats Intoxicated with Aflatoxin B1
- (2020) Mohammed S. Aleissa et al. Oxidative Medicine and Cellular Longevity
- Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
- (2020) Mădălina Ioana Moisi et al. Medicina-Lithuania
- The Role of Caspase-2 in Regulating Cell Fate
- (2020) Vasanthy Vigneswara et al. Cells
- Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
- (2020) Cosmin Mihai Vesa et al. Diagnostics
- Protective effects of Artemisia judaica extract compared to metformin against hepatorenal injury in high-fat diet/streptozotocine-induced diabetic rats
- (2020) Gadah Albasher et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin
- (2020) Zeinab A. Saad et al. LIFE SCIENCES
- Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
- (2020) Yi-Chou Hou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Sitagliptin protects Diabetic Rats with Acute Myocardial Infarction Involves Induction of Angiogenesis: Role of IGF-1 and VEGF
- (2019) Dina M Khodeer et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
- (2019) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling
- (2019) Fengjuan Huang et al. Frontiers in Endocrinology
- Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
- (2018) Chiara Ghezzi et al. DIABETOLOGIA
- Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
- (2018) Seigo Sugiyama et al. Journal of Atherosclerosis and Thrombosis
- VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes
- (2018) Qin Zhang et al. MEDICINE
- Adipose-derived stem cells: Effectiveness and advances in delivery in diabetic wound healing
- (2018) Mohamed Gadelkarim et al. BIOMEDICINE & PHARMACOTHERAPY
- Aqueous humor pentraxin-3 levels in patients with diabetes mellitus
- (2017) M Mutlu et al. EYE
- Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis
- (2016) Dina M. Khodeer et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease
- (2016) Omar C. Logue et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Pentraxins in the activation and regulation of innate immunity
- (2016) Kenji Daigo et al. IMMUNOLOGICAL REVIEWS
- Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation
- (2015) Huaibin Sun et al. INFLAMMATION
- Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
- (2015) B. Sjöberg et al. JOURNAL OF INTERNAL MEDICINE
- Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
- (2014) Elaine Hui et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Renal histologic changes and the outcome in patients with diabetic nephropathy
- (2014) Y. An et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR-192, a Smad3-dependent microRNA
- (2013) JUN-PING HONG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The interstitial expression of alpha-smooth muscle actin in glomerulonephritis is associated with renal function
- (2013) Zana Saratlija Novakovic et al. MEDICAL SCIENCE MONITOR
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- VEGF and Podocytes in Diabetic Nephropathy
- (2012) Alda Tufro et al. SEMINARS IN NEPHROLOGY
- VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition
- (2011) Yao-guo Lian et al. ACTA PHARMACOLOGICA SINICA
- Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria
- (2011) TOMONARI OKADA et al. NEPHROLOGY
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
- (2008) S. Han et al. DIABETES
- Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients
- (2008) Alicia Jenkins et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Role of Inflammatory Cytokines in Diabetic Nephropathy
- (2008) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now